Michigan Mounjaro Stomach Paralysis Lawsuit (2024 Update)

Michigan Mounjaro Stomach Paralysis Lawsuit Overview

Mounjaro (tirzepatide) lawsuits are currently being filed nationwide by patients who suffered stomach paralysis or gastroparesis after taking the medication.

These lawsuits allege that Eli Lilly failed to adequately warn patients and healthcare providers about the serious risk of severe stomach emptying complications associated with the drug.

The FDA has received numerous adverse event reports linking Mounjaro to gastroparesis and other digestive disorders, with patients experiencing debilitating symptoms that often persist even after discontinuing the medication.

Latest Mounjaro Lawsuit Updates

• February 1, 2024 – The Mounjaro lawsuit litigation in Michigan is gaining traction as more patients come forward with experiences of severe side effects. Courts are evaluating the admissibility of evidence, including medical records, expert testimonies, and internal documents from Eli Lilly.
• January 15, 2024 – Attorneys across the country are consolidating cases against Eli Lilly, the manufacturer of Mounjaro, as reports of gastroparesis continue to increase. Legal experts predict this could become a significant mass tort lawsuit.
• December 5, 2023 – The FDA announced enhanced monitoring of GLP-1 receptor agonists including Mounjaro following increasing reports of severe gastrointestinal complications including gastroparesis and stomach paralysis.
• October 30, 2023 – Initial lawsuits were filed alleging that Eli Lilly knew or should have known about the risk of gastroparesis associated with Mounjaro but failed to provide adequate warnings to patients and healthcare providers.

FDA Reports and Statistics

According to the FDA’s MAUDE (Manufacturer and User Facility Device Experience) database, there have been:

• Over 2,500 adverse event reports related to Mounjaro since its approval
• Approximately 30% of these reports involve severe gastrointestinal complications
• 15% specifically mention gastroparesis or stomach paralysis symptoms
• Multiple reports of patients requiring hospitalization due to severe dehydration and malnutrition

The FDA has not yet issued a recall but has emphasized the importance of monitoring patients taking Mounjaro for signs of gastroparesis.

Mounjaro Injuries & Side Effects

Mounjaro (tirzepatide) has been linked to several serious gastrointestinal complications, with stomach paralysis (gastroparesis) being among the most severe.

• Gastroparesis/Stomach Paralysis: Severe slowing or stopping of stomach emptying, leading to nausea, vomiting, and inability to digest food
• Intestinal Obstruction: Blockage preventing food from passing through the digestive tract
• Persistent Vomiting: Severe, uncontrollable vomiting requiring medical intervention
• Malnutrition: Inability to absorb nutrients due to digestive complications
• Severe Abdominal Pain: Intense, persistent pain that may require hospitalization
• Dehydration: Dangerous fluid loss from persistent vomiting and inability to maintain hydration

Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit?

You may qualify for a Mounjaro lawsuit if:

• You were prescribed and used Mounjaro (tirzepatide) for diabetes or weight loss
• You developed gastroparesis or stomach paralysis symptoms after starting Mounjaro
• Your symptoms required medical attention, hospitalization, or ongoing treatment
• You can provide medical documentation linking your injuries to Mounjaro use
• You are within the statute of limitations for filing a claim in your state

Evidence Required for a Mounjaro Lawsuit

Building a strong Mounjaro lawsuit requires comprehensive evidence, including:

• Medical records documenting the diagnosis and treatment of stomach paralysis
• Expert testimonies linking Mounjaro to your condition
• Personal testimonies detailing the impact of the side effects on daily life
• Internal documents from the manufacturer that may reveal knowledge of the drug’s risks
• Communications between you and your healthcare providers regarding the use of Mounjaro and its side effects

Damages You Can Recover

Victims of Mounjaro-related injuries may be entitled to compensation for:

• Medical expenses for current and future treatment
• Lost wages and diminished earning capacity
• Pain and suffering, including physical and emotional distress
• Punitive damages against the manufacturer (in cases of proven negligence)
• Costs associated with ongoing care and lifestyle modifications

Mounjaro Recall Information

As of February 2024, there has been no official recall of Mounjaro by the FDA or Eli Lilly.

However, the increasing number of adverse event reports and lawsuits may lead to enhanced warnings or potential recall actions in the future.

The FDA continues to monitor reports of serious gastrointestinal complications associated with Mounjaro and other GLP-1 receptor agonists like Ozempic.

Statute of Limitations for Mounjaro Lawsuits

The statute of limitations for Mounjaro lawsuits in Michigan is generally three years from the date of the injury or when the injury was discovered.

This narrow window of time means that affected individuals must act promptly to initiate legal action and preserve their rights.

Statutes of limitations vary by state, ranging from 1-6 years, making it crucial to consult with experienced attorneys as soon as possible if you suspect a Mounjaro-related injury.

Related Article: Weight Loss Drug Stomach Paralysis Attorney

Frequently Asked Questions

1. What Is Mounjaro and How Does It Differ from Ozempic?

Mounjaro (tirzepatide) is a diabetes medication designed to improve blood sugar control and assist with weight loss [2]. Unlike Ozempic (semaglutide), Mounjaro targets both GIP and GLP-1 receptors, potentially leading to more significant weight loss but also potentially different side effect profiles.

2. How Does Mounjaro Cause Stomach Paralysis?

Mounjaro slows gastric emptying as part of its mechanism of action. In some patients, this effect becomes severe, leading to gastroparesis where the stomach’s muscles cannot properly contract to move food through the digestive system, resulting in food remaining in the stomach for abnormally long periods.

3. What Compensation Amounts Are Being Sought in Mounjaro Lawsuits?

While specific settlement amounts vary, victims are seeking compensation for medical expenses, lost wages, pain and suffering, and in some cases, punitive damages. Similar GLP-1 medication lawsuits have sought damages ranging from $100,000 to several million dollars depending on the severity of injuries.

4. Can I Join a Class Action Lawsuit Against Eli Lilly for Mounjaro Injuries?

Currently, Mounjaro cases are being handled as individual personal injury claims rather than class actions. However, as more cases are filed, they may be consolidated into multidistrict litigation (MDL) to streamline pretrial proceedings while maintaining individual case valuations.

5. How Long Does It Take to Resolve a Mounjaro Lawsuit?

Most pharmaceutical liability cases take between 1-3 years to resolve, depending on case complexity and whether they settle or go to trial. Mounjaro litigation is still in early stages, so timeframes may vary as the litigation develops.

6. Are Weight Loss Benefits Worth the Risks of Mounjaro?

While Mounjaro has proven effective for weight loss and diabetes management, the risk of serious side effects like gastroparesis must be carefully considered. Always consult with healthcare providers about potential risks versus benefits, especially given the emerging litigation surrounding GLP-1 medications.

7. Which Attorneys Are Handling Mounjaro Stomach Paralysis Cases?

Schmidt & Clark, LLP specializes in pharmaceutical liability cases including Mounjaro lawsuits. Our team has extensive experience handling cases involving severe medication side effects and works on a contingency fee basis, meaning you pay nothing unless we win your case.

8. How Are Mounjaro Lawsuits Different from Other Weight Loss Drug Litigation?

Mounjaro lawsuits focus specifically on severe gastrointestinal complications like gastroparesis, while other weight loss drug litigation may involve different side effects. The dual-receptor mechanism of Mounjaro (affecting both GIP and GLP-1) distinguishes these cases from other weight loss medication lawsuits.

Get A Free Michigan Mounjaro Stomach Paralysis Lawsuit Evaluation With Our Lawyers

Time is limited to pursue legal action for Mounjaro-related injuries. In Michigan, you have only three years from the date of injury to file a claim, and this window may be closing quickly for early users of the medication.

Our services include:

• Free, confidential consultations
• No upfront costs or fees
• Payment only if we win your case
• Comprehensive case evaluation by experienced attorneys
• Access to medical experts specializing in gastroparesis and medication side effects

Don’t delay in seeking the compensation you deserve for Mounjaro-related injuries. The experienced attorneys at Schmidt & Clark, LLP understand the complexities of pharmaceutical liability cases and are ready to fight for your rights.

Reference:

1. https://www.healthline.com/health/drugs/mounjaro